{"organizations": [], "uuid": "a3c157dc0f2f6e0f18c6421affe1c3276798a2ae", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180215.html", "section_title": "Archive News &amp; Video for Thursday, 15 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-akcea-therapeutics-says-fda-adviso/brief-akcea-therapeutics-says-fda-advisory-committee-meeting-to-review-data-supporting-volanesorsen-nda-idUSFWN1Q51IL", "country": "US", "domain_rank": 408, "title": "BRIEF-Akcea Therapeutics says ‍FDA Advisory Committee Meeting To Review Data Supporting Volanesorsen NDA", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.031, "site_type": "news", "published": "2018-02-16T07:00:00.000+02:00", "replies_count": 0, "uuid": "a3c157dc0f2f6e0f18c6421affe1c3276798a2ae"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-akcea-therapeutics-says-fda-adviso/brief-akcea-therapeutics-says-fda-advisory-committee-meeting-to-review-data-supporting-volanesorsen-nda-idUSFWN1Q51IL", "ord_in_thread": 0, "title": "BRIEF-Akcea Therapeutics says ‍FDA Advisory Committee Meeting To Review Data Supporting Volanesorsen NDA", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-akcea therapeutics", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "fda advisory committee meeting to review data supporting volanesorsen nda", "sentiment": "negative"}, {"name": "fda advisory committee", "sentiment": "negative"}, {"name": "akcea therapeutics inc", "sentiment": "negative"}, {"name": "fda", "sentiment": "none"}, {"name": "nda", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 15 (Reuters) - Akcea Therapeutics Inc:\n* AKCEA THERAPEUTICS- ‍FDA ADVISORY COMMITTEE MEETING TO REVIEW DATA SUPPORTING VOLANESORSEN NDA; MEETING TENTATIVELY SCHEDULED FOR MAY 10\n* AKCEA THERAPEUTICS INC - ‍ FDA SET A PDUF GOAL DATE OF AUGUST 30, 2018 FOR COMPLETION OF REVIEW​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-16T07:00:00.000+02:00", "crawled": "2018-02-16T17:14:45.000+02:00", "highlightTitle": ""}